Recurrent respiratory tract infections
Conditions
Interventions
Control group:Health education only
experimental group:Tuina treatment group
Sponsors
Chongqing Health Center for Women and Children
Eligibility
Sex/Gender
All
Age
2 Years to 5 Years
Inclusion criteria
Inclusion criteria: 1: Meeting the diagnostic and pattern identification criteria 2: aged 2–5 years,regardless of gender 3: in a non-acute infection phase 4: able to cooperate with treatment and follow-up 5: completing the full course of therapy 6: the legal guardian of the child has provided informed consent and signed the informed consent form
Exclusion criteria
Exclusion criteria: 1: Children who have received treatment with other immunomodulatory agents within the past 12 months 2: children with primary immunodeficiency disorders, pulmonary hypoplasia, or swallowing dysfunction 3: children with severe concomitant primary diseases involving the heart, liver, kidneys, digestive system, or hematopoietic system 4: individuals with iatrogenic immune deficiency caused by long-term use of glucocorticoids, immunosuppressants, cytotoxic drugs, radiotherapy, or prolonged antibiotic use 5: children who are uncooperative or currently participating in other drug trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall clinical response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum immunoglobulin levels;Duration of each infection episode;Traditional Chinese Medicine syndrome score;Height and weight gain;Incidence of adverse events; | — |
Countries
China
Contacts
Public ContactXuemeiLi
Chongqing Health Center for Women and Children
Outcome results
None listed